Vitiligo, affecting over 90 per cent of patients in its non-segmental form, is characterized by symmetrical white patches on both sides of the body
AI-powered cardiometabolic wellness platform for India’s workforce
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
Ticagrelor tablets are indicated for reducing the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients
Tourmaline is now an indirect wholly owned subsidiary of Novartis
The SELECT-SWITCH study, first head-to-head Phase 3b/4 trial, compared switching to Rinvoq versus switching to another TNF inhibitor
This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
FineCross M3 empowers physicians to perform safer PCI procedures, helping improve outcomes in patients with challenging coronary anatomies
Subscribe To Our Newsletter & Stay Updated
